Table 4.
No. | Studies | Study Population | Patient Selection | Study Design | Analysis and Data Presentation | Total Score | Level of Studies |
---|---|---|---|---|---|---|---|
1 | Krause 1997 | 0 | 1 | 4 | 3 | 8 | High |
2 | Levy 1998 | 1 | 1 | 2 | 0 | 4 | Low |
3 | Yeo 1998 | 1 | 1 | 3 | 1 | 6 | Moderate |
4 | O’Connor 2005 | 1 | 1 | 3 | 3 | 8 | High |
5 | Lidal 2007 | 1 | 1 | 3 | 2 | 7 | moderate |
6 | Leal-Filho 2008 | 1 | 1 | 3 | 1 | 6 | Moderate |
7 | Furlan 2009 | 1 | 1 | 3 | 3 | 8 | High |
8 | Divanoglou 2010 | 1 | 1 | 3 | 1 | 6 | Moderate |
9 | Furlan 2010 | 1 | 1 | 4 | 3 | 9 | High |
10 | Hagen 2010 | 1 | 1 | 3 | 3 | 8 | High |
11 | Ning 2010 | 1 | 1 | 3 | 1 | 6 | Moderate |
12 | Varma 2010 | 1 | 1 | 3 | 3 | 8 | High |
13 | Ahoniemi 2011 | 1 | 1 | 3 | 1 | 6 | Moderate |
14 | Krause 2011 | 1 | 1 | 3 | 3 | 8 | High |
15 | Krause 2011 | 1 | 1 | 4 | 3 | 9 | High |
16 | Kawu 2011 | 1 | 1 | 3 | 1 | 6 | Moderate |
17 | Grossman 2012 | 1 | 1 | 3 | 2 | 7 | Moderate |
18 | Middleton 2012 | 1 | 1 | 4 | 2 | 8 | Moderatea |
19 | Cao 2013 | 1 | 1 | 4 | 3 | 9 | High |
20 | Nwankwo 2013 | 1 | 1 | 2 | 1 | 5 | Moderate |
21 | Sabre 2013 | 1 | 1 | 2 | 2 | 6 | Moderate |
22 | Löfvenmark 2014 | 0 | 1 | 3 | 2 | 6 | moderate |
23 | Barman2014 | 1 | 1 | 3 | 3 | 8 | High |
24 | Hossain 2015 | 1 | 1 | 4 | 2 | 8 | Moderatea |
Multivariate analysis has been performed;
Multivariate analysis has not been performed